Observational studyFrontiers in endocrinology2026
Neuroretinal damage associated with pituitary macroadenoma: endocrine and radiological predictors and correlation with optical coherence tomography-derived biomarkers.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify endocrine and radiological tumor characteristics associated with higher risk of visual impairment. Methods: A retrospective observational study included 40 patients with pituitary macroadenoma. Variables analyzed were age, sex, disease duration, treatment, hormonal profile, tumor volume, and ophthalmic parameters: visual acuity (VA), perimetry, and retinal analysis using optical coherence tomography (OCT). Results: Surgery normalized ACTH, cortisol, IGF-1, and prolactin levels. Larger tumor volumes were observed in males, nonfunctioning tumors, nonoperated patients, and relapses. Larger tumors were associated with worse visual field, while VA remained stable. OCT showed thinning of total retina and inner retinal layers in patients with disease duration >5 years, nonfunctioning tumors, larger tumors, postoperative status, and relapse (p < 0.05). Macular ganglion cell layer thickness correlated inversely with IGF-1 and prolactin, and retinal nerve fiber layer with tumor size. The inner nuclear layer exhibited a non-linear behavior, thickening in early stages while thinning in severe injury. Conclusion: Hormonal and radiological factors are associated with visual dysfunction. OCT and perimetry detect early visual pathway damage better than VA. Non-linear behavior of the INL stand out as a potential prognostic biomarker.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.